VH6

Plerixafor

Created:	2023-09-12
Last modified:	2024-03-13

Find Related PDB Entry
2 entries where VH6 is found as a standalone ligand

Find related ligands: Help
Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	90
Chiral Atom Count	0
Bond Count	92
Aromatic Bond Count	6

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	Plerixafor
Synonyms	1,1'-[1,4-phenylenebis(methylene)]bis(1,4,8,11-tetraazacyclotetradecane); AMD3100
Systematic Name (OpenEye OEToolkits)	1-[[4-(1,4,8,11-tetrazacyclotetradec-1-ylmethyl)phenyl]methyl]-1,4,8,11-tetrazacyclotetradecane
Formula	C₂₈ H₅₄ N₈
Molecular Weight	502.782
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	C1NCCCNCCN(Cc2ccc(CN3CCCNCCNCCCNCC3)cc2)CCCNC1
SMILES	CACTVS	3.385	C1CNCCNCCCN(CCNC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2
SMILES	OpenEye OEToolkits	2.0.7	c1cc(ccc1CN2CCCNCCNCCCNCC2)CN3CCCNCCNCCCNCC3
Canonical SMILES	CACTVS	3.385	C1CNCCNCCCN(CCNC1)Cc2ccc(CN3CCCNCCNCCCNCC3)cc2
Canonical SMILES	OpenEye OEToolkits	2.0.7	c1cc(ccc1CN2CCCNCCNCCCNCC2)CN3CCCNCCNCCCNCC3
InChI	InChI	1.06	InChI=1S/C28H54N8/c1-9-29-15-17-31-13-3-21-35(23-19-33-11-1)25-27-5-7-28(8-6-27)26-36-22-4-14-32-18-16-30-10-2-12-34-20-24-36/h5-8,29-34H,1-4,9-26H2
InChIKey	InChI	1.06	YIQPUIGJQJDJOS-UHFFFAOYSA-N

Drug Info: DrugBank

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

DrugBank ID	DB06809
Name	Plerixafor
Description	Plerixafor is a hematopoietic stem cell mobilizer. It is used to stimulate the release of stem cells from the bone marrow into the blood in patients with non-Hodgkin lymphoma and multiple myeloma for the purpose of stimulating the immune system. These stem cells are then collected and used in autologous stem cell transplantation to replace blood-forming cells that were destroyed by chemotherapy. Plerixafor has orphan drug status in the United States and European Union; it was approved by the U.S. Food and Drug Administration on December 15, 2008.
Synonyms	Plerixafor octahydrochloride Plerixafor
Indication	Used in combination with granulocyte-colony stimulating factor (G-CSF, filgrastim) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with non-Hodgkin’s lymphoma (NHL) and multiple myeloma (MM).
Categories	Adjuvants, Immunologic Amines Anti-HIV Agents Anti-Infective Agents Antineoplastic and Immunomodulating Agents Benzene Derivatives Benzyl Compounds Drugs that are Mainly Renally Excreted Hematinics Hematopoietic Stem Cell Mobilizer Increased Hematopoietic Stem Cell Mobilization Polyamines
ATC-Code	L03AX16
CAS number	110078-46-1

Drug Targets

DrugBank data are sourced from datasets licensed under a Creative Common's Attribution-NonCommercial 4.0 International License

Name	Target Sequence	Pharmacological Action	Actions
C-X-C chemokine receptor type 4	MEGISIYTSDNYTEEMGSGDYDSMKEPCFREENANFNKIFLPTIYSIIFL...	unknown	antagonist,inhibitor

Drug Info/Drug Targets: DrugBank 3.0: a comprehensive resource for 'omics' research on drugs. Knox C, Law V, Jewison T, Liu P, Ly S, Frolkis A, Pon A, Banco K, Mak C, Neveu V, Djoumbou Y, Eisner R, Guo AC, Wishart DS. Nucleic Acids Res. 2011 Jan; 39 (Database issue):D1035-41. | PMID:21059682